Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Medically reviewed by Doru Paul, MD Leukemia is a cancer of the blood-forming tissues that often develops in the bone marrow.

Hemogenyx Pharmaceuticals plc, a publicly traded company headquartered in London, announced the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed/refractory (R/R) ...

MAX-4 is under clinical development by MaxiNovel Pharmaceuticals and currently in Phase I for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). According to GlobalData, Phase I drugs for ...

Asma had been diagnosed with acute myeloid leukaemia, an aggressive cancer of the bone marrow and the blood ... leukaemia usually does not develop into a mass (tumor) that appears on imaging tests ...

Asma, 49, was first diagnosed with acute myeloid leukemia in May 2024, a rare and aggressive form of blood cancer. This diagnosis reportedly came just a few years after her successful treatment ...

Using CT scans, scientists in Catalonia have gained new insights into the internal structure of hailstones, revealing details about their formation and growth that challenge previous assumptions about ...

A CT scan and other tests revealed a grim diagnosis a few days later. Acute myeloid leukemia – a rare, fast-growing blood and bone marrow cancer originating from abnormal blood stem cells ...

CML is characterized by the presence of a unique gene mutation called the Philadelphia chromosome. Unlike acute myeloid leukemia, CML involves more mature cells of myeloid origin. If left untreated, ...